Ophthotech reported $163.69M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Alimera Sciences ALIM:US $ 45.24M 14.91M
Applied Genetic Technologies AGTC:US $ 113.02M 57.85M
Cytrx CYTR:US 8.76M 1.27M
Insmed INSM:US $ 1.04B 537.19M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Novartis NOVN:VX 23.81B 1.61B
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M